| Swift Biosciences–Danaher: investment, 202103 acquisition €na of Swift Biosciences by Integrated DNA Technologies |
2021-03-11 |
| Cognate BioServices–Charles River: investment, 202102– acquisition $875m in cash by Charles River ANNOUNCED |
2021-02-17 |
| Thermo Fisher–Sidis: cell sorting technology, 202102 acquisition cell sorting assets incl Bigfoot Spectral Cell Sorter + 40 employees from Propel Labs |
2021-02-17 |
| Tecan–UgenTec: laboratory automation, 202102– collab product integration of Tecan workstations with FastFinder qPCR-s/w for sale in dx markets |
2021-02-04 |
| Avacta–Adeptrix: MS-based SARS-CoV-2 test, 202101 collab existent developm of BAMS SARS-CoV-2 assay for research + IVD |
2021-01-28 |
| Avacta–Bruker: MS-based SARS-CoV-2 test, 202101– collab developm of BAMS SARS-CoV-2 assay on Bruker MALDI-TOF as IVD test |
2021-01-28 |
| Mobilion–Protein Metrics: mass spectrometry software, 202101– collab integration of Byos software suit with Mobilion HRIM MS system |
2021-01-26 |
| i3 Membrane–High-Tech Gründerfonds: investment, 202101 financing round totalling 7-figure € sum inkl existing investor HTGF |
2021-01-25 |
| i3 Membrane–OTHER: investment, 202101 financing round totalling 7-figure € sum incl three private investors |
2021-01-25 |
| i3 Membrane–SEVERAL: investment, 202101 financing round 7-figure € sum from HTGF + three private investors |
2021-01-25 |
| Intabio–Danaher: investment, 202101 acquisition $na of Intabio Inc by Sciex |
2021-01-21 |
| Numares–Bruker: NMR spectroscopy, 202102– collab developm + product integration Axinon platform for metabolomics-based NMR-CDx |
2021-01-21 |
| Mesa Biotech–Thermo Fisher: investment, 202101– acquisition $450m cash upfront + $100m cash milestones of Mesa Biotech Inc by Thermo Fisher |
2021-01-19 |
| Novasep–Thermo Fisher: investment, 202101 acquisition €725m in cash of viral vector manufacturing business Henogen SA in Belgium by Thermo Fisher |
2021-01-15 |
| Labforward–2mag: investment, 202101 financing round Series B totalling >€5m incl new + co-investor 2mag |
2021-01-11 |
| Labforward–Peppermint: investment, 202101 financing round Series B totalling >€5m incl existing + co-investor Peppermint VenturePartners |
2021-01-11 |
| Labforward–SEVERAL: investment, 202101 financing round Series B >€5m led by Tecan + incl 2mag + Peppermint VenturePartners |
2021-01-11 |
| Labforward–Tecan: investment, 202101 financing round Series B totalling >€5m incl €4m from new + lead investor Tecan resulting in 10% stake |
2021-01-11 |
| IsoPlexis–SEVERAL: credit, 202101– credit facility $50m |
2021-01-07 |
| IsoPlexis–SEVERAL: investment, 202101 financing round Series D $85m led by new investor Perceptive Advisors |
2021-01-07 |
| Oxford Immunotec–PerkinElmer: investment, 202101– acquisition $591m with $22/share in cash ANNOUNCED |
2021-01-07 |
| Adeptrix–Bruker: investment, 202101 financing round Series A incl new + minority investor Bruker Corp |
2021-01-06 |
| Adeptrix–SEVERAL: investment, 202101 financing round Series A closed with new + minority investor Bruker Corp |
2021-01-06 |
| Distributed Bio–Charles River: investment, 202012 acquisition $83m upfront cash + $21m milestones |
2020-12-31 |
| Phitonex–Thermo Fisher: investment, 202012 acquisition fo Phitonex by Thermo Fisher Scientific |
2020-12-31 |
| SomaLogic–Amgen: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Amgen |
2020-12-22 |
| SomaLogic–Boston Millennia Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Boston Millenia Partners |
2020-12-22 |
| SomaLogic–Intermountain Ventures: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Intermountain Ventures |
2020-12-22 |
| SomaLogic–Janus Henderson: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Janus Henderson Investors |
2020-12-22 |
| SomaLogic–Logos Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Logos Capital |
2020-12-22 |
| SomaLogic–Millenium Management: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Millennium Management |
2020-12-22 |
| SomaLogic–NEC: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl NEC Solution Innovators Ltd |
2020-12-22 |
| SomaLogic–Novartis: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Novartis |
2020-12-22 |
| SomaLogic–Redmile Group: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Redmile Group |
2020-12-22 |
| SomaLogic–Revelation Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Revelation Partners |
2020-12-22 |
| SomaLogic–SEVERAL: investment, 202012 financing round Series A 2nd closing additional $81m bringing total Series A to $204m or $214m |
2020-12-22 |
| SomaLogic–Ziff Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Ziff Capital Healthcare Ventures |
2020-12-22 |
| 908 Devices–SEVERAL: investment, 202012 IPO $130m+$19.5m with 6.5m+975k shares common stock at $20/share at Nasdaq Global Market |
2020-12-18 |
| Kyungpook National Univ–Waters: mass spectrometer, 202012 supply first Select Series Cyclic IMS system in South Korea to S Kim |
2020-12-08 |
| Waters–Kyungpook National Univ: mass spectrometry, 202012– collab research expansion with S Kim using Cyclic IMS system for crude oil analysis |
2020-12-08 |
| Newomics–SEVERAL: investment, 202012 financing round Series B $7.9m led by MSA Capital |
2020-12-01 |
| Slack Technologies–Salesforce: investment, 202012– acquisition $27.7b in cash + shares of Slack by Salesforce ANNOUNCED |
2020-12-01 |
| SomaLogic–SEVERAL: investment, 202011 financing round Series A initial closing $121m led by Casdin Capital |
2020-11-25 |
| Univ Pennsylvania–Agilent: grant, 202011– Thought Leader Award to Carl H June + M Milone at School of Medicine for cancer cell therapy |
2020-11-17 |
| m2p-labs–Danaher: investment, 202011 acquisition of m2p-biolabs by Beckman Coulter Life Sciences |
2020-11-12 |
| Eurofins–Waters: mass spectrometer, 202011 supply existent Radian ASAP System beta customer Eurofins Forenscis Teddington |
2020-11-02 |
| Horizon Discovery–PerkinElmer: investment, 202011– cash tender offer £296m ($383m) representing total enterprise value of £284m ($368m) |
2020-11-02 |
| BIA Separations–Sartorius: investment, 202010– acquisition €240m in cash + €120m in SSB shares BIA to be merged into SSB ANNOUNCED |
2020-10-02 |
| Integrated Proteomics Applications–Bruker: investment, 202009 acquisition €na of assets by Bruker |
2020-09-30 |
| Prolytic–Kymos: investment, 202009 strategic merger of Polytic GmbH + Kymos SL |
2020-09-28 |
| Canopy Biosciences–Bruker: investment, 202009 acquisition €na of Canopy Biosciences LLC by Bruker Corp |
2020-09-11 |
| Helmholtz–Bruker: NMR spectrometer, 202009c supply 1.2 GHz NMR spectrometer with 28 Tesla to FZ Jülich |
2020-09-01 |
| Univ Guelph–Bruker: NMR spectrometer, 202008 supply existent of 400 MHz NMR spectrometer + Fourier 80 benchtop NRM system |
2020-08-24 |
| Mobilion–SEVERAL: investment, 202008 financing round Series B $35m led by aMoon + incl Agilent + IP Group + Hostplus + Cultivation Capital |
2020-08-17 |
| Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab |
2020-08-07 |
| DNA Script–SEVERAL: investment, 202007 financing round Series B extension $50m led by Casdin Capital |
2020-07-29 |
| Resolution Spectra Systems–Merck (DE): investment, 202007 acquisition €na of Resolution Spectra Systems by Merck |
2020-07-01 |
| Waters–Heidrick & Struggles: recruitment services, 202007 supply service placement of Udit Batra as CEO of Waters |
2020-07-01 |
| Univ Bochum–Max Planck: antibiotics research, 202006– collab establishment CESAR Center for Antibiotics Research at Univ Bochum with LDC |
2020-06-18 |
| Univ Bochum–North Rhine-Westphalia (govt): grant, 202006– grant €4m from NRW + EFRO for establishment CESAR Center for Antibiotics Research with LDC |
2020-06-18 |
| Gustave Roussy–Biognosys: MS-based proteomics, 202004– collab using proteomic profiling in attempt to repurpose tocilizumab for Covid-19 |
2020-04-28 |
| Danaher–UDG Healthcare: public relations, 202003 service existent for Cepheid by Canale Communciations |
2020-03-21 |
| Agilent–Visiopharm: image analysis software, 202003– collab co-marketing of Visiopharm’s AI-driven solutions for digital pathology |
2020-03-02 |
| Sterling Pharma Solutions–Thermo Fisher: LC system, 202003 supply early customer for Vanquish Core HPLC System |
2020-03-02 |
| Danaher–Sherlock Biosciences: molecular diagnostics, 202002– collab developm of Cepheid GeneXpert tests using CRISPR-based SHERLOCK technology |
2020-02-28 |
| InstruNor–Fluidigm: investment, 202002 acquisition $7.2m with $5.2m in cash + $2m in stock |
2020-02-26 |
| BIA Separations–Univ Zagreb: purification technology, 202002– commercial license + collab developm of virus + viral vector immunoaffinity purification |
2020-02-19 |
| OMass–SEVERAL: investment, 202002 financing round Series A extension £27.5m bringing total Series A to £41.5m |
2020-02-17 |
| NanoPin Technologies–Thermo Fisher: mass spectrometry, 202002– collab developm LC-MS-based workflows for blood-based infectious disease diagnostics |
2020-02-13 |
| Fluidigm–Georgetown Univ: mass cytometry, 202002– collab establishment of joint CoE for Imaging Mass Cytometry at Georgetown Lombardi CCC |
2020-02-10 |
| Georgetown Univ–Fluidigm: mass cytometry, 202002– supply Hyperion Imaging System for new CoE for Imaging Mass Cytometry at GLCCC |
2020-02-10 |
| LabCorp–Fluidigm: mass cytometry, 202002– supply Covance selects CyTOF technology incl Maxpar Direct Immune Profiling Assay for drug dev services |
2020-02-10 |
| Cognate BioServices–Essex Woodlands: investment, 202001 financing round Series B incl existing + lead investor EW Healthcare Partners |
2020-01-21 |
| Cognate BioServices–Medivate Partners: investment, 202001 financing round Series B incl co-investor Medivate Partners |
2020-01-21 |
| Cognate BioServices–SEVERAL: investment, 202001 financing round Series B led by EW Healthcare Partners + incl Medivate Partners |
2020-01-21 |
| Piramal–Onex Corp: investment, 201901– acquisition Decision Resources by Clarivate Analytics from Piral Enterprises Ltd for $900m cash + $50m shares |
2020-01-17 |
| Danaher–Sophia Genetics: genomic technologies, 202001– collab ww expansion IDT NGS enrichment products with Sophia Genetics DDM for clinical research |
2020-01-15 |
| Andrew Alliance–Waters: investment, 202001 acquisition by existent investor Waters |
2020-01-13 |
| Bruker–Adeptrix: MS-based immunoassays, 202101– collab developm BAMS assays on Bruker MALDI-MS systems |
2020-01-06 |
| BugLab–Aber Instruments: investment, 202009–202102 acquisition €na of assets of BugLab LLC incl IP + trademarks |
2020-01-01 |
| Tecan–Labforward: laboratory software, 2020– collab integration of Tecan detection devices with Labfolder LIMS |
2020-01-01 |
| Promega–Merck (DE): CRISPR technology, 201912– license to CRISPR IP io from Merck to Promega to develop CRISPR-edited cell lines |
2019-12-19 |
| Schauenburg–JP Scientific: SPE technology, 201912– ww commercial license + supply to Markes from JP Scientific Ltd |
2019-12-10 |
| EMBL–Bruker: microscope, 201912 supply existent early customer EMBL for new Luxendo TruLive3D Imager |
2019-12-09 |
| Indivumed–Biognosys: MS-based proteomics, 201912– collab integration of HRM MS proteomics data into multi-omics IndivuType cancer database |
2019-12-02 |
| Mobilion–SEVERAL: investment, 201911 financing round Series A $15.4m led by Agilent |
2019-11-12 |
| Aston Univ–Waters: mass spectrometer, 201911 supply first Select Series Cyclic IMS mass spectrometer installed at School of Health + Life Sciences |
2019-11-07 |
| Owlstone–Thermo Fisher: mass spectrometry, 201911– collab integration of Q Exactive GC Hybrid Quad-Orbitrap MS into Breath Biopsy platform |
2019-11-07 |
| Greenough–KDM Communications: investment, 201911 merger combination to provide transatlantic PR services |
2019-11-06 |
| Cobra Biologics–Cognate BioServices: investment, 201911–202001 acquisition of Cobra by Cognate BioServices |
2019-11-04 |
| Danaher–Sartorius: investment, 201910– acquisition $750m three life science businesses by Sartorius part of regulatory clearance for GE/Danaher deal |
2019-10-21 |
| Waters–Salesforce: CRM cloud software, 201910– supply Waters to use Sales Cloud Einstein + Service Cloud + Einstein Analytics |
2019-10-16 |
| FloDesign Sonics–Merck (DE): investment, 201910 acquisition €na by Merck |
2019-10-10 |
| Dalhousie Univ–Thermo Fisher: mass spectrometer, 201910 supply C$1.3m of Orbitrap Fusion MS system to MS + Proteomics Core Faclity |
2019-10-07 |
| Lundbeck–LeadXPro: drug discovery services, 201910– collab structural proteomics services using X-ray + cryo-EM for small molecule drug discovery |
2019-10-07 |
| Freiberg Instruments–Bruker: investment, 201910 acquisition €na of Magnettech EPR business by Bruker |
2019-10-02 |
| Creoptix–SEVERAL: investment, 201909 financing round Series 1st closing CHF8m incl investors Swisscanto Invest + Waters |
2019-09-30 |
| Creoptix–Waters: investment, 201909 financing round Series 1st closing totalling CHF8m incl existing + co-investor Waters Corp |
2019-09-30 |
| Creoptix–Zürcher Kantonalbank: investment, 201909 financing round Series 1st closing totalling CHF8m incl new + lead investor Swisscanto Invest |
2019-09-30 |
| Danaher–Protein Metrics: bioinformatics, 201909– collab extension integration of Protein Metrics s/w suite with Sciex HRAM systems |
2019-09-30 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectronomy-portal-logo-2019.png){kind=logo}
Date![Picture [iito] No Tracking 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-tracking.jpg){kind=tracking}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
